BioSpace News Archive

The industry analysis report is considered a valuable source of information about the global Rehabilitation Robots industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Collegium Pharmaceutical, Inc. announced that the Company will host a conference call and live audio webcast on Thursday, February 24, 2022, at 4:30 p.m. Eastern Time.

Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to supply up to 600,000 doses of investigational drug bebtelovimab for at least $720 million.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), today reported business and financial results for the first fiscal quarter of 2022 ended December 31, 2021.

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage gamma-delta T cell therapies biopharmaceutical company today announced that Company executives will be presenting at the following events.

TriSalus Life Sciences®, today announced the addition of three new members to its Scientific Advisory Boards and two new members of its clinical leadership team, Drs. Alexander Kim and John Hardaway, as director of interventional oncology clinical strategies and strategic immunotherapy advisor, respectively.

The Feinstein Institutes for Medical Research, the research home of Northwell Health, has named Anil K. Malhotra, MD, co-director of the Institute of Behavioral Science.

Thunder11, which has specializations in technology, healthcare, and public affairs, will be involved in raising BioHarvest’s profile with media relations, partners, and other influential audiences.

Dr. Sessa Will Discuss the Promise of Psychedelic Medicine in Treating Addiction.

Number Of Commercially Available Orphan Drugs In Market Is Expected Increase 25% By 2028 Says Kuick Research.